Raltegravir demonstrates potency.
D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D015337:Multicenter Studies as Topic; D009930:Organic Chemicals / Q000627:therapeutic use*; D011760:Pyrrolidinones; D000068898:Raltegravir Potassium; D016032:Randomized Controlled Trials as Topic; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use*
D009930:Organic Chemicals; D011760:Pyrrolidinones; D018894:Reverse Transcriptase Inhibitors; D000068898:Raltegravir Potassium